Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome

NCT03665077 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Aromatase Inhibitor Induced Musculoskeletal Syndrome (AIMSS)
Breast Cancer

Interventions

DIAGNOSTIC_TEST: Initial blood draw
DIAGNOSTIC_TEST: Initial SWE ultrasound
DIAGNOSTIC_TEST: Blood draw at three months
DIAGNOSTIC_TEST: Blood draw at six months
DIAGNOSTIC_TEST: SWE ultrasound at six months

Sponsor

University of Arizona